Nephrology
Starting from
$2,000
Up to $10,000 depending on centre
Typical duration
7–21 days
Including pre-operative work-up
Partner hospitals
1
Vetted for outcome data & accreditation
Content reviewed for medical accuracy by: Dr. Rodina Ainasoa · Medical Content Writer & Health Communications
Expert diagnosis and treatment of glomerulonephritis and nephrotic syndrome through kidney biopsy, immunosuppressive therapy, and specialist nephrology follow-up at internationally accredited centers. International patients gain access to experienced nephrologists and pathologists who manage rare conditions often under-diagnosed in their home countries.
Your case is matched to a centre on the basis of clinical outcome data, not marketing. We coordinate every step — from pre-operative work-up to post-treatment follow-up — with a dedicated care coordinator.
Glomerular Disease Management
Coordinated from
or message us on WhatsApp
No commitment required. Your data is never shared with third parties.
Glomerular diseases are treated very differently depending on the specific diagnosis found on kidney biopsy. Here is how a conservative, supportive approach compares with immunosuppressive therapy for more active disease.
| Parameter | Conservative / Supportive Management | Immunosuppressive Therapy |
|---|---|---|
| Primary goal | Protect kidney function and control symptoms — blood pressure, swelling, protein loss — without suppressing the immune system. | Suppress the underlying immune-mediated injury to the kidney's filtering units and induce disease remission. |
| Typical candidates | Milder or non-progressive presentations, such as low-level proteinuria with preserved kidney function, or biopsy findings showing limited active inflammation. | More active or progressive disease on biopsy — for example lupus nephritis, ANCA-associated vasculitis, or FSGS and minimal change disease with heavy proteinuria. |
| Core measures | ACE inhibitors or ARBs to reduce proteinuria and control blood pressure, SGLT2 inhibitors where appropriate, dietary sodium restriction, and diuretics for swelling. | Corticosteroids combined with agents such as mycophenolate mofetil, cyclophosphamide, calcineurin inhibitors, rituximab, or belimumab depending on the specific diagnosis, per KDIGO guidance. |
| Monitoring intensity | Periodic blood pressure, urine protein, and kidney function checks, typically every few months. | Frequent early monitoring — often monthly or more — for treatment response, infection risk, and medication side effects, tapering in frequency as disease stabilizes. |
| Key trade-off | Lower risk of medication side effects, but may not halt disease progression if underlying inflammation is active. | Greater chance of inducing remission in active disease, but carries meaningful risks of infection and other side effects that must be weighed against expected benefit. |
The steps below outline a typical pathway for diagnosing and managing a glomerular disease. Your nephrologist will confirm the exact plan based on your biopsy result and specific diagnosis.
Diagnostic workup and kidney biopsy
Blood and urine tests, imaging, and a percutaneous kidney biopsy performed under ultrasound guidance are used to determine the specific glomerular disease affecting you, since treatment differs significantly by diagnosis.
Pathology review and treatment planning
A nephropathologist examines the biopsy tissue under light microscopy, immunofluorescence, and electron microscopy, and your nephrologist uses this result to build a treatment plan tailored to your specific condition, such as IgA nephropathy, FSGS, membranous nephropathy, or lupus nephritis.
Initiating therapy
Depending on the diagnosis and severity, therapy may involve supportive medications alone, or immunosuppressive treatment such as corticosteroids and steroid-sparing agents, introduced under close supervision to manage side effects.
Monitoring response and adjusting treatment
Regular blood and urine tests track how well the kidneys are responding, allowing your nephrologist to adjust medication doses, watch for relapse, and screen for treatment-related complications over time.
Early follow-up focuses on confirming the biopsy diagnosis, starting the treatment plan, and monitoring for immediate medication side effects or biopsy-related complications, per National Kidney Foundation guidance.
Urine protein and kidney function are checked frequently to assess early treatment response; immunosuppressive doses are commonly adjusted during this period based on how the disease is responding.
For many glomerular diseases, this is when remission — partial or complete — becomes evident, per KDIGO guidance; medication tapering may begin if the disease has responded well, while non-responders may need a change in therapy.
Ongoing nephrology follow-up continues indefinitely for most patients, since relapse is possible and long-term kidney function must be tracked, even after successful treatment.
Source: National Kidney Foundation; KDIGO 2021/2024/2025 Clinical Practice Guidelines for the Management of Glomerular Diseases; Mayo Clinic; Cleveland Clinic. Individual monitoring plans vary and are guided by your treating nephrologist.
Known Risks & Limitations
Source: National Kidney Foundation; KDIGO Clinical Practice Guidelines for the Management of Glomerular Diseases; Mayo Clinic; Cleveland Clinic. No treatment is without risk; your treating nephrologist will review your individual case.
Remote case review
Share your prior test results, urine and blood work, and any imaging with our coordination team, who forward your case for an initial nephrology review of whether a kidney biopsy or further workup is likely to change your management.
Nephrologist and pathologist matching
We match you with an accredited nephrology center experienced in glomerular disease diagnosis, including on-site nephropathology capable of light microscopy, immunofluorescence, and electron microscopy review.
Cost estimate and travel planning
Once your case is reviewed, we issue a consolidated cost estimate covering consultation, biopsy, pathology, and initial treatment, and help plan a trip length that allows time for biopsy results and treatment initiation.
Biopsy, diagnosis, and treatment initiation
You undergo the kidney biopsy and initial workup, receive your diagnosis and treatment plan from your nephrologist, and begin therapy under close monitoring before you travel home.
Long-term follow-up and continuity of care
Before you depart, your biopsy report, diagnosis, and treatment plan are shared with your home-country nephrologist so they can continue monitoring and adjusting your care over the long term.
Average coordinated costs across our partner centres. Final pricing depends on clinical complexity and chosen hospital.
| Country | Avg. cost | vs. cheapest |
|---|---|---|
🇮🇳 India New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi | $3,000 | —chevron_right |
🇹🇷 Turkey Istanbul | $5,000 | +67%chevron_right |
Costs are indicative estimates and vary by procedure specifics, hospital, and clinical complexity. Request a personalised estimate for your specific case.
Gurugram, India
Medanta Hospital branch. Located in Delhi NCR, it serves Gurugram Sector 14 and surrounding areas. Established in 2022, it operates 250 beds with 100 doctors across cardiology, oncology, haematology, neurology, orthopaedics and fertility, holds NABH and NABL accreditation, and offers procedures including liver transplantation and living-donor liver transplant.
100+
Specialists
250+
Beds
A percutaneous kidney biopsy performed under ultrasound guidance by an experienced interventional nephrologist or radiologist is safe, with major complication rates (significant bleeding requiring transfusion or intervention) below 1% at high-volume centers. The procedure itself takes 20–30 minutes under local anesthesia with light sedation. Post-procedure, you are monitored for 6–12 hours in a day-care or ward setting. Most patients are discharged the same day or the following morning. We recommend remaining in the country for at least 3 days post-biopsy to allow for monitoring and initial histopathology results. Full electron microscopy results typically take 5–7 days, and final reporting with treatment recommendations is provided before you depart or sent electronically.
No fees. No commitment.
We are compensated by our partner hospitals — never by patients. You get independent clinical matching, cost transparency, and end-to-end coordination at no cost to you.
